<?xml version='1.0' encoding='utf-8'?>
<document id="25966009"><sentence text="Simultaneous determination of centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS/MS."><entity charOffset="30-41" id="DDI-PubMed.25966009.s1.e0" text="centchroman" /><entity charOffset="46-55" id="DDI-PubMed.25966009.s1.e1" text="tamoxifen" /><pair ddi="false" e1="DDI-PubMed.25966009.s1.e0" e2="DDI-PubMed.25966009.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25966009.s1.e0" e2="DDI-PubMed.25966009.s1.e1" /></sentence><sentence text="Tamoxifen and centchroman are two non-steroidal, selective estrogen receptors modulators, intended for long term therapy in the woman"><entity charOffset="0-9" id="DDI-PubMed.25966009.s2.e0" text="Tamoxifen" /><entity charOffset="59-67" id="DDI-PubMed.25966009.s2.e1" text="estrogen" /><pair ddi="false" e1="DDI-PubMed.25966009.s2.e0" e2="DDI-PubMed.25966009.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25966009.s2.e0" e2="DDI-PubMed.25966009.s2.e1" /></sentence><sentence text=" Because of their wide spread use, there is a possibility of co-prescription of these agents" /><sentence text="" /><sentence text="We studied the probable pharmacokinetic interaction between these agents in breast cancer model rats" /><sentence text=" A simple, sensitive and rapid LC-ESI-MS/MS method was developed and validated for the simultaneous determination of tamoxifen, centchroman and their active metabolites"><entity charOffset="117-126" id="DDI-PubMed.25966009.s6.e0" text="tamoxifen" /><entity charOffset="128-139" id="DDI-PubMed.25966009.s6.e1" text="centchroman" /><pair ddi="false" e1="DDI-PubMed.25966009.s6.e0" e2="DDI-PubMed.25966009.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25966009.s6.e0" e2="DDI-PubMed.25966009.s6.e1" /></sentence><sentence text="" /><sentence text="The method was linear over a range of 0" /><sentence text="2-200 ng/ml" /><sentence text=" All validation parameters met the acceptance criteria according to regulatory guidelines" /><sentence text="" /><sentence text="LC-MS/MS method for determination of tamoxifen, centchroman and their metabolites was developed and validated"><entity charOffset="37-46" id="DDI-PubMed.25966009.s12.e0" text="tamoxifen" /><entity charOffset="48-59" id="DDI-PubMed.25966009.s12.e1" text="centchroman" /><pair ddi="false" e1="DDI-PubMed.25966009.s12.e0" e2="DDI-PubMed.25966009.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25966009.s12.e0" e2="DDI-PubMed.25966009.s12.e1" /></sentence><sentence text=" Results show the potential of drug-drug interaction upon co-administration these two marketed drugs" /><sentence text="" /></document>